Adverse effects by frequency include: ;Very common (>10% frequency): * Diarrhea (>90%) * Rash/dermatitis acneform * Stomatitis * Paronychia * Decreased appetite * Nose bleed * Itchiness * Dry skin ;Common (1–10% frequency): * Dehydration * Taste changes * Dry eye * Cystitis * Cheilitis * Fever * Runny/stuffy nose * Low amount of potassium in the blood * Conjunctivitis * Increased ALT * Increased AST * Hand-foot syndrome * Muscle spasms * Kidney impairment and/or failure ;Uncommon (0.1-1% frequency): * Keratitis * Interstitial lung disease
Afatinib
Imatinib
Neratinib
Dasatinib
Capmatinib
Tucatinib
Ponatinib
Lapatinib